Registration Dossier
Registration Dossier
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 204-263-4 | CAS number: 118-60-5
Endpoint summary
Administrative data
Link to relevant study record(s)
Description of key information
2-Ethylhexyl salicylate can be well absorbed via the dermal and the oral route of exposure.
Inhalative exposure is not relevant due to low vapour pressure. No accumulation in the body is expected due to efficient metabolic pathways and formation of soluble degradation products (salicylic acid and 2-ethylhexanol) with established elimination routes.
Key value for chemical safety assessment
- Bioaccumulation potential:
- no bioaccumulation potential
Additional information
It is concluded that the absorption of 2-ethylhexyl salicylate via the dermal route is very low (3%), while it is well absorbed via the oral route (100% absorption assumed). Following absorption, 2-ethylhexyl salicylate is metabolized to salicylic acid and 2-ethylhexanol rapidly. Salicylic acid is mainly excreted by renal excretion as an unchanged chemical entity or after conjugation with glycine as salicyluric acid. 2-Ethylhexanol is metabolized following metabolic pathways of alcohols with its degradation products mainly excreted in respiratory CO2, via faeces and urine. No accumulation in the body is expected due to efficient metabolic pathways and formation of soluble degradation products (salicylic acid and 2-ethylhexanol) with established elimination routes.
Due to low vapor pressure (1.8E-4hPa at 20 °C, Symrise) and high boiling point (> 300 °C, Intertek ASG), the inhalation route is not considered to be a relevant exposure route to human for 2-ethylhexyl salicylate.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
